Copyright
©The Author(s) 2015.
World J Cardiol. Mar 26, 2015; 7(3): 150-156
Published online Mar 26, 2015. doi: 10.4330/wjc.v7.i3.150
Published online Mar 26, 2015. doi: 10.4330/wjc.v7.i3.150
Amplatzer | Cardioseal/STARflex | |
5 yr follow-up available, n (%) | 58 (76.3) | 23 (82.1) |
New-onset SVT | ||
0-1 yr | 5 (6.6) | 5 (17.9) |
> 1 yr | 3 (3.9) | 0 |
Reoccurrence TIA/stroke | ||
0-1 yr | 0 | 1 (3.6) |
> 1 yr | 2 (2.6) | 0 |
TTE > 5 yr FU available, n | 46 | 11 |
RLS | ||
No shunt | 38 (82.6) | 6 (54.5) |
Minimal | 5 (10.9) | 3 (27.3) |
Moderate | 1 (2.2) | 2 (18.2) |
Severe | 2 (4.3) | 0 |
LRS | 0 | 0 |
Follow up (yr) | 6.6 (5.0-11.1) | 9.9 (6.3-13.4) |
- Citation: Snijder RJ, Suttorp MJ, Berg JMT, Post MC. Percutaneous closure of secundum type atrial septal defects: More than 5-year follow-up. World J Cardiol 2015; 7(3): 150-156
- URL: https://www.wjgnet.com/1949-8462/full/v7/i3/150.htm
- DOI: https://dx.doi.org/10.4330/wjc.v7.i3.150